Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Substance Name: MEDI 551
Long-term subcutaneous interferon beta-1a therapy in patients with relapsing-remitting MS.
Validation of semaphorin 7A and ala-β-his-dipeptidase as biomarkers associated with the conversion from clinically isolated syndrome to multiple sclerosis.
Cognitive dysfunction in early multiple sclerosis: altered centrality derived from resting-state functional connectivity using magneto-encephalography.
[The use of modern neuroimaging methods in studies of mechanisms of development cognitive disturbances in patients with multiple sclerosis].
Monoclonal Antibodies in the Treatment of Neuroimmunological Diseases.
The thalamus and multiple sclerosis: Modern views on pathologic, imaging, and clinical aspects.
Cannabinoids in the management of difficult to treat pain.
Biogen Idec to acquire full rights and control of Tysabri from Elan for upfront cash and contingent payments
[Autophagy and its role in protective and damaging inflammatory response].
Geographical Variations in Sex Ratio Trends over Time in Multiple Sclerosis.
[Neuromyelitis optica spectrum disorder: a case report].
Riluzole specifically blocks inactivated Na channels in myelinated nerve fibre.
Enhanced myelination in autoimmunity and in normal development induced by glatiramer acetate.
[Damage of macular ganglion cell complex and peripapillary retinal nerve fiber layer in multiple sclerosis.]
[Prevention of multiple sclerosis: A realistic goal?]
Regulation of Neuroinflammation through Programed Death-1/Programed Death Ligand Signaling in Neurological Disorders.
Mortality in multiple sclerosis: meta-analysis of standardised mortality ratios.
Integrin/Chemokine Receptor Interactions in the Pathogenesis of Experimental Autoimmune Encephalomyelitis.
Natalizumab restores aberrant miRNA expression profile in multiple sclerosis and reveals a critical role for miR-20b.
Association between parasite infection and immune responses in multiple sclerosis.
Quality of Life Assessment in Patients with Multiple Sclerosis Receiving Interferon Beta-1a: A Comparative Longitudinal Study of Avonex and Its Biosimilar CinnoVex.
Increased risk of multiple sclerosis relapse after in vitro fertilisation.
Dual-Task Assessment in Natalizumab-Treated Multiple Sclerosis Patients.
Gray matter involvement in multiple sclerosis.

Pages